The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus Lifesciences Ltd.
“We have always believed in evolving and transforming ourselves in the ongoing quest to bring patient-centric solutions driven by science and innovation.-Pankaj R. Patel, Chairman, Zydus Lifesciences Ltd., said
“With these attributes close to our heart, we wish to make a meaningful difference in serving patients and communities. These pillars of care, compassion, and commitment to innovation will remain at the heart of all that Zydus stands for,” Sharvil Patel, Managing Director, said.
Sharing his insights on the new identity, Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., said “Our new brand identity is a confluence of what we truly are. A global Lifesciences company is driven by the purpose of delivering care and nurturance for the patients, backed by the power of innovation, science, and cutting-edge technology. With these attributes close to our hearts, we wish to make a meaningful difference in serving patients and communities. These pillars of care, compassion, and commitment to innovation will remain at the heart of all that Zydus stands for.”
In the new logo, two hearts come together to enclose ‘us’ at the core. The heart represents the company’s inclusiveness. The Teal and Purple colors represent the pillars of science and care. While the dynamic teal expresses Zydus’ dynamism and stands for the company’s commitment to science, the purposeful purple stands for dedication to care and nurturance.
The ‘us’ in the new Zydus logo represents all the stakeholders including employees, patients, doctors, investors, bankers, business partners, associates, and all those who are an integral part of Zydus’ journey.
Recently, the company began the first supply of ZyCoV-D, the world’s first Plasmid DNA Vaccine for human use, to the government.